| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma
|
Shin, Ho-Jin
|
|
2012
|
69 |
5 |
p. 1165-1172
|
artikel
|
| 2 |
Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies
|
Falchook, G. S.
|
|
2011
|
69 |
5 |
p. 1117-1126
|
artikel
|
| 3 |
A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer
|
Karachaliou, N.
|
|
2012
|
69 |
5 |
p. 1345-1352
|
artikel
|
| 4 |
Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial
|
Berk, Lori
|
|
2012
|
69 |
5 |
p. 1369-1377
|
artikel
|
| 5 |
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer
|
Renouf, Daniel J.
|
|
2012
|
69 |
5 |
p. 1339-1344
|
artikel
|
| 6 |
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers
|
Lin, Che
|
|
2012
|
69 |
5 |
p. 1363-1368
|
artikel
|
| 7 |
A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer
|
Kobayashi, Takashi
|
|
2012
|
69 |
5 |
p. 1241-1246
|
artikel
|
| 8 |
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures
|
Takahara, Takeshi
|
|
2011
|
69 |
5 |
p. 1127-1133
|
artikel
|
| 9 |
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
|
Girish, Sandhya
|
|
2012
|
69 |
5 |
p. 1229-1240
|
artikel
|
| 10 |
Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells
|
Hu, Xiaogang
|
|
2012
|
69 |
5 |
p. 1205-1212
|
artikel
|
| 11 |
Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection
|
Lu, Jian-Feng
|
|
2011
|
69 |
5 |
p. 1135-1144
|
artikel
|
| 12 |
Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
|
Dong, Ningning
|
|
2012
|
69 |
5 |
p. 1315-1322
|
artikel
|
| 13 |
Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells
|
Yu, Yong-sheng
|
|
2012
|
69 |
5 |
p. 1173-1180
|
artikel
|
| 14 |
Mass balance, excretion and metabolism of [14C] ASA404 in cancer patients in a phase I trial
|
McKeage, M. J.
|
|
2011
|
69 |
5 |
p. 1145-1154
|
artikel
|
| 15 |
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers
|
del Corral, Adam
|
|
2012
|
69 |
5 |
p. 1255-1263
|
artikel
|
| 16 |
Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials
|
Yu, Yong
|
|
2012
|
69 |
5 |
p. 1265-1275
|
artikel
|
| 17 |
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations
|
Ludovini, V.
|
|
2012
|
69 |
5 |
p. 1289-1299
|
artikel
|
| 18 |
Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats
|
Kapetanovic, Izet M.
|
|
2012
|
69 |
5 |
p. 1301-1306
|
artikel
|
| 19 |
Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial
|
Kitagawa, Chiyoe
|
|
2012
|
69 |
5 |
p. 1379-1385
|
artikel
|
| 20 |
Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer
|
Lee, Duk Joo
|
|
2012
|
69 |
5 |
p. 1333-1338
|
artikel
|
| 21 |
Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
|
Kanai, Masashi
|
|
2012
|
69 |
5 |
p. 1181-1188
|
artikel
|
| 22 |
Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice
|
Gong, Jian-hua
|
|
2012
|
69 |
5 |
p. 1323-1332
|
artikel
|
| 23 |
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
|
Krogh-Madsen, Mikkel
|
|
2011
|
69 |
5 |
p. 1155-1163
|
artikel
|
| 24 |
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index
|
Hetland, Thea Eline
|
|
2012
|
69 |
5 |
p. 1307-1314
|
artikel
|
| 25 |
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma
|
Alexiou, George A.
|
|
2012
|
69 |
5 |
p. 1387-1391
|
artikel
|
| 26 |
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy
|
Kim, Kyu-pyo
|
|
2012
|
69 |
5 |
p. 1221-1227
|
artikel
|
| 27 |
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
|
Ozaka, Masato
|
|
2012
|
69 |
5 |
p. 1197-1204
|
artikel
|
| 28 |
RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer
|
Zhang, Guo Bing
|
|
2012
|
69 |
5 |
p. 1277-1287
|
artikel
|
| 29 |
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients
|
Walko, Christine M.
|
|
2012
|
69 |
5 |
p. 1189-1196
|
artikel
|
| 30 |
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus
|
Stroh, Mark
|
|
2012
|
69 |
5 |
p. 1247-1253
|
artikel
|
| 31 |
The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials
|
Wang, Ye-min
|
|
2012
|
69 |
5 |
p. 1213-1220
|
artikel
|
| 32 |
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment
|
Ozawa, Yoichi
|
|
2012
|
69 |
5 |
p. 1353-1362
|
artikel
|
Tijdschrift beschrijving